FDA Inspection 1028549 — Providence Tarzana Medical Center
The FDA completed an inspection of Providence Tarzana Medical Center on September 28, 2017 in Tarzana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tarzana, CA (United States)